Unity Biotechnology logo

Unity Biotechnology share price today

(UBX)

Unity Biotechnology share price is $1.79 & ₹155.08 as on 11 Jan 2025, 2.30 'hrs' IST

$1.79

0.46

(34.59%)

Market is closed - opens 8 PM, 13 Jan 2025

View live Unity Biotechnology share price in Dollar and Rupees. Guide to invest in Unity Biotechnology stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Unity Biotechnology, along with analyst recommendations, forecasts, and comprehensive financials.

Unity Biotechnology share price movements

  • Today's Low: $1.37
    Today's High: $1.80

    Day's Volatility :23.89%

  • 52 Weeks Low: $0.94
    52 Weeks High: $2.02

    52 Weeks Volatility :53.48%

Unity Biotechnology Returns

PeriodUnity Biotechnology, Inc.Russel 2000Index (Russel 2000)
3 Months
22.6%
0.0%
0.0%
6 Months
14.74%
0.0%
0.0%
1 Year
0.56%
0.0%
0.0%
3 Years
-87.91%
-18.1%
-18.1%

Unity Biotechnology Key Statistics

in dollars & INR

Previous Close
$1.33
Open
$1.41
Today's High
$1.8
Today's Low
$1.37
Market Capitalization
$30.2M
Today's Volume
$748.4K
52 Week High
$2.02
52 Week Low
$0.9397
Revenue TTM
$0.0
EBITDA
$-27.4M
Earnings Per Share (EPS)
$-1.28
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-86.95%

How to invest in Unity Biotechnology from India?

It is very easy for Indian residents to invest directly in Unity Biotechnology from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Unity Biotechnology stock in both Indian Rupees (INR) and US Dollars (USD). Search for Unity Biotechnology or UBX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Unity Biotechnology or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Unity Biotechnology shares which would translate to 0.484 fractional shares of Unity Biotechnology as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Unity Biotechnology, in just a few clicks!

Returns in Unity Biotechnology for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Unity Biotechnology investment value today

Current value as on today

₹1,05,087

Returns

₹5,087

(+5.09%)

Returns from Unity Biotechnology Stock

₹562 (+0.56%)

Dollar Returns

₹4,526 (+4.53%)

Indian investors sentiment towards Unity Biotechnology

29%

Period: Oct 14, 2024 to Jan 12, 2025. Change in 30 Days versus previous period

Search volume for Unity Biotechnology on INDmoney from India has grown in the last 30 days as on Jan 13, 2025. 29% more investors are searching Unity Biotechnology in the last 30 days versus the previous period.

Global Institutional Holdings in Unity Biotechnology

  • ARCH VENTURE CORP

    5.96%

  • Alyeska Investment Group, L.P.

    5.46%

  • Vanguard Group Inc

    3.51%

  • Geode Capital Management, LLC

    0.97%

  • Mayo Clinic

    0.74%

  • Renaissance Technologies Corp

    0.56%

Analyst Recommendation on Unity Biotechnology

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Unity Biotechnology(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Unity Biotechnology

What analysts predicted

Upside of 272.44%

Target:

$6.67

Current:

$1.79

Insights on Unity Biotechnology

  • Price Movement

    In the last 1 month, UBX stock has moved up by 59.8%
  • UBX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.1% return, outperforming this stock by 26.9%
  • UBX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 60.8% return, outperforming this stock by 148.1%

Unity Biotechnology Technicals Summary

Sell

Neutral

Buy

Unity Biotechnology is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Unity Biotechnology Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Unity Biotechnology, Inc. logo
65.74%
14.74%
0.56%
-87.91%
-97.53%
Regeneron Pharmaceuticals, Inc. logo
-3.86%
-35.6%
-25.65%
13.27%
78.34%
Biontech Se logo
7.56%
45.82%
23.38%
-37.32%
255.57%
Alnylam Pharmaceuticals, Inc. logo
-2.46%
-7.1%
26.93%
60.26%
101.52%
Vertex Pharmaceuticals Incorporated logo
-12.5%
-16.56%
-6.38%
74.98%
74.91%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Unity Biotechnology, Inc. logo
NA
NA
NA
-1.44
-0.87
-0.3
NA
0.84
Regeneron Pharmaceuticals, Inc. logo
17.24
17.24
1.03
44.96
0.17
0.07
NA
272.04
Biontech Se logo
160.8
NA
0.04
-3.2
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.07
0.49
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Unity Biotechnology, Inc. logo
Buy
$30.2M
-97.53%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$76.6B
78.34%
17.24
33.61%
Biontech Se logo
Buy
$29.5B
255.57%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc. logo
Buy
$30.7B
101.52%
NA
-15.86%
Vertex Pharmaceuticals Incorporated logo
Buy
$105.5B
74.91%
32.84
-4.51%

About Unity Biotechnology

Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase 2 clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2048, a Tie2/VEGF bispecific; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.
Organization
Unity Biotechnology
Employees
19
CEO
Dr. Anirvan Ghosh Ph.D.
Industry
Health Technology

Management People of Unity Biotechnology

NameTitle
Dr. Anirvan Ghosh Ph.D.
CEO & Director
Dr. Nathaniel E. David A.B., Ph.D.
Co-Founder & Executive Director
Ms. Lynne Marie Sullivan CPA
CFO & Head of Corporate Development
Mr. Alexander Hieu Nguyen J.D.
Chief Legal Officer, Head of Operations & Corporate Secretary
Dr. Jan M. van Deursen
Founder
Mr. Daohong Zhou M.D.
Founder
Dr. Przemyslaw Sapieha Ph.D.
Chief Scientist
Ms. Alicia Tozier M.B.A.
Chief Strategy Officer
Dr. Federico Grossi M.D., Ph.D.
Chief Medical Officer

Important FAQs about investing in Unity Biotechnology from India :

What is Unity Biotechnology share price today?

Unity Biotechnology share price today stands at $1.79, Open: $1.41 ; Previous Close: $1.33 ; High: $1.80 ; Low: $1.37 ; 52 Week High: $2.02 ; 52 Week Low: $0.94. The stock opens at $1.41, after a previous close of $1.33. The stock reached a daily high of $1.80 and a low of $1.37, with a 52-week high of $2.02 and a 52-week low of $0.94.

Can Indians buy Unity Biotechnology shares?

Yes, Indians can invest in the Unity Biotechnology (UBX) from India.

With INDmoney, you can buy Unity Biotechnology at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Unity Biotechnology at zero transaction cost.

How can I buy Unity Biotechnology shares from India?

It is very easy to buy Unity Biotechnology from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Unity Biotechnology be purchased?

Yes, you can buy fractional shares of Unity Biotechnology with INDmoney app.

What are the documents required to start investing in Unity Biotechnology stocks?

To start investing in Unity Biotechnology, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Unity Biotechnology

Today’s highest price of Unity Biotechnology (UBX) is $1.80.

Today’s lowest price of Unity Biotechnology (UBX) is $1.37.

What is today's market capitalisation of Unity Biotechnology

Today's market capitalisation of Unity Biotechnology UBX is 30.2M

What is the 52 Week High and Low Range of Unity Biotechnology

  • 52 Week High

    $2.02

  • 52 Week Low

    $0.94

What are the historical returns of Unity Biotechnology?

  • 1 Month Returns

    65.74%

  • 3 Months Returns

    14.74%

  • 1 Year Returns

    0.56%

  • 5 Years Returns

    -97.53%

Who is the Chief Executive Officer (CEO) of Unity Biotechnology

Dr. Anirvan Ghosh Ph.D. is the current Chief Executive Officer (CEO) of Unity Biotechnology.